- Pharmacovigilance and Adverse Drug Reactions
- Computational Drug Discovery Methods
- Hepatitis C virus research
- Statistical Methods in Clinical Trials
- Primary Care and Health Outcomes
- Liver Disease Diagnosis and Treatment
- Health Policy Implementation Science
- Biosimilars and Bioanalytical Methods
- Telemedicine and Telehealth Implementation
- Liver Disease and Transplantation
University at Buffalo, State University of New York
2022-2024
Facilitated telemedicine may promote hepatitis C virus elimination by mitigating geographic and temporal barriers.
The safety of medical products due to adverse events (AE) from drugs, therapeutic biologics, and devices is a major public health concern worldwide. Likelihood ratio test (LRT) approaches pharmacovigilance constitute class rigorous statistical tools that permit objective identification AEs specific drug and/or drugs cataloged in spontaneous reporting system databases. However, the existing LRT encounter certain theoretical computational challenges when an underlying Poisson model assumption...
<title>Abstract</title> Background Hybrid effectiveness-implementation designs evaluate the effectiveness and implementation of interventions. We retrospectively evaluated a stepped-wedge cluster randomized controlled trial (RCT) facilitated telemedicine model (experimental) integrated into opioid treatment programs (OTPs) compared to offsite referral (control) for hepatitis C virus (HCV) treatment. organizational characteristics associated with an HCV cure high healthcare delivery...
The safety of medical products continues to be a significant health concern worldwide. Spontaneous reporting systems (SRS) and pharmacovigilance databases are essential tools for postmarketing surveillance products. Various SRS employed globally, such as the Food Drug Administration Adverse Event Reporting System (FAERS), EudraVigilance, VigiBase. In literature, numerous methods have been proposed assess product - adverse event pairs potential signals. this paper, we introduce an R Python...